Archive for November 2019

Originally designed to treat cardiovascular diseases, phosphodiesterase-5 (PDE5) inhibitors made a major splash on the pharmaceutical market in 1998 with the approval of Viagra®. By far, it was the blockbuster drug of the decade. Other PDE5 inhibitors were soon to follow, and patent-expiration dates have been an interesting phenomenon to watch, with multiple extensions involved.…

Compounded bioidentical hormone replacement therapy (BHRT) is an important treatment option for women around the world. Providers and patients alike come to Pavilion Compounding Pharmacy, LLC for guidance about this, and our recommendations are based on knowledge about the available delivery options and their impact on safety. In the area of BHRT, some new information…